期刊文献+

血管紧张素受体及其拮抗剂在心力衰竭中的作用机理 被引量:5

原文传递
导出
摘要 心力衰竭的防治是目前研究的重点课题,随着血管紧张素受体研究的不断深入,新型抗心力衰竭制剂-血管紧张素受体拮抗剂正越来越受人们重视。除传统的肾素-血管紧张素系统(RAS)外,近年研究发现心脏还有局部的肾素-血管紧张素系统,血管紧张素Ⅱ(AngⅡ)通过内...
出处 《心功能杂志》 1998年第3期163-164,共2页
  • 相关文献

同被引文献34

  • 1金有豫 陈新谦 金有豫.降压药物[A].陈新谦,金有豫.新编药物学(第14版)[M].北京:人民卫生出版社,1997.280.
  • 2Tsutamoto T, Wada A, Maeda K, et al.Effect of spironolactone on plasma brain natriuretic peptide and legt ventricular remodeling in patients with congestive heart failure[J].J Am Coll Cardiol, 2001, 37(5): 1228-1233.
  • 3Collucci WS. Molecular and cellular mechanisms of myocardial failure[J]. Am J Cardiol, 1997,80:15-25.
  • 4Paradis P, Dali-Youcef N, Paradis FW,et al.Overexpression of angiotensin II type I receptor in cardiomyocytes induces cardiac hypertrophy and remodeling[J]. Proe Natl Acad Sci U S A, 2000, 97(2):931-936.
  • 5Faiez Z, Brigitte D, Francois A. Treatment of congestive heart failure interfering the aldosterone-cardiac extracellular matrix relationship[J].Hypertension,2001,38:1227-1232.
  • 6Zhou G, Brilla CG, Weber KT,et al. Angiotensin II-mediated stimulation ofcollagen synthesis in cultured cardiac fibroblasts[J]. Faseb J,1992,6(5):1914-1918.
  • 7Mann DL. Recent insights into the role of tumor necrosis factor in thefailing heart[J].Heart Fail Rev,2001,6(2):71-80.
  • 8Aaker SD, Ponikowski P, Varney S,et al.Wasting as independent risk factor for mortality in chronic heart failure[J]. Lancet,1997,349:1050-1053.
  • 9Milani RV, Endres S, Eigler A,et al.The clinical relevance of circulating tumor necrosis factor-alpha in acute decompensated chronic heart failure without cachexia[J]. Chest,1996,110:992-995.
  • 10Civertz , Collucci WS. New targets for heart-failure therapy:endothelin,inflaatory, cytokine, oxidative stress[J].Lancet,1998,352:34-38.

引证文献5

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部